What the company does
Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with excision of …
What the weekly tape is saying
COPN closed the latest completed week at 75.50 EUR. The 4-week return is -9.9% and the 12-week return is -9.3%. Trend Signal is inactive, Market Dynamics is -0.84. Setup signature: Risk-first tape with a 32/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 99.62 EUR
- Vs Trend Line
- -24.2%
- Fair Value
- 75.32 EUR
- Vs Fair Value
- 0.2%
- 52W High
- 138.1 EUR
- 52W Low
- 56.32 EUR
- Drawdown
- -45.3%
- Range Position
- 23.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 34
- 52W Active Breadth
- 65.4%
- Sector Scope
- AT Healthcare
- Sector Rank
- 100 of 112
- Sector Percentile
- 10.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 95 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Drug Manufacturers - General
- Tracked Peers
- 17
- 4W Rank
- 17 of 17
- Avg 1W
- -0.8%
- Avg 4W
- 2.5%
- Trend Breadth
- 58.8%
- Positive RS
- 17.6%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.84
- 4W MD Change
- 5.5%
- Relative Strength
- -26.48
- 4W RS Change
- -104.9%
- Expectation
- Positive
- Probability
- 66.46%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 237
- 13W Average
- 85
- 52W Average
- 34
- Vs 13W
- 2.8x
- Vs 52W
- 7.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.5%
- 52W Volatility
- 8.3%
- Upside Weeks
- 28
- Downside Weeks
- 21
- Downside Breadth
- 40.4%
- Avg Gain / Loss
- 5.8% / -6.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
- Market Cap
- 1.4B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- Latest weekly return ranks in the weaker part of its sector group.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 75.50 EUR | -4.9% | 99.62 EUR | 75.32 EUR | -0.84 | -26.48 | 237 | Off |
| 5 Jun 2026 | 79.40 EUR | -7.1% | 99.42 EUR | 75.31 EUR | -0.85 | -20.66 | 101 | Off |
| 29 May 2026 | 85.50 EUR | -0.5% | 98.96 EUR | 75.27 EUR | -0.87 | -15.58 | 100 | Off |
| 22 May 2026 | 85.90 EUR | 2.5% | 98.49 EUR | 75.15 EUR | -0.88 | -12.74 | 115 | Off |
| 15 May 2026 | 83.80 EUR | 3.7% | 98.06 EUR | 75.02 EUR | -0.89 | -12.92 | 106 | Off |
| 8 May 2026 | 80.80 EUR | -9.7% | 97.54 EUR | 74.92 EUR | -0.86 | -16.16 | 0 | Off |
| 1 May 2026 | 89.50 EUR | -9.4% | 97.18 EUR | 74.85 EUR | -0.82 | -5.50 | 0 | Off |
| 24 Apr 2026 | 98.80 EUR | -4.5% | 96.58 EUR | 74.67 EUR | -0.77 | 5.50 | 0 | On |
| 17 Apr 2026 | 103.4 EUR | 7.2% | 95.51 EUR | 74.37 EUR | -0.83 | 7.36 | 0 | Off |
| 10 Apr 2026 | 96.48 EUR | 6.5% | 94.43 EUR | 74.01 EUR | -0.90 | 3.24 | 0 | Off |
| 3 Apr 2026 | 90.61 EUR | 5.1% | 93.58 EUR | 73.72 EUR | -0.89 | 3.78 | 449 | Off |
| 27 Mar 2026 | 86.20 EUR | 3.5% | 92.84 EUR | 73.50 EUR | -0.59 | 2.55 | 0 | On |
| 20 Mar 2026 | 83.26 EUR | -11.9% | 92.17 EUR | 73.34 EUR | -0.11 | 0.84 | 0 | On |
| 13 Mar 2026 | 94.52 EUR | -17.5% | 91.42 EUR | 73.21 EUR | 0.46 | 13.40 | 0 | On |